These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21554935)

  • 1. Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy.
    Roger M; Clavreul A; Huynh NT; Passirani C; Schiller P; Vessières A; Montero-Menei C; Menei P
    Int J Pharm; 2012 Feb; 423(1):63-8. PubMed ID: 21554935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
    Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP
    Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules.
    Clavreul A; Montagu A; Lainé AL; Tétaud C; Lautram N; Franconi F; Passirani C; Vessières A; Montero-Menei CN; Menei P
    Int J Nanomedicine; 2015; 10():1259-71. PubMed ID: 25709447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo interactions between glioma and marrow-isolated adult multilineage inducible (MIAMI) cells.
    Roger M; Clavreul A; Sindji L; Chassevent A; Schiller PC; Montero-Menei CN; Menei P
    Brain Res; 2012 Sep; 1473():193-203. PubMed ID: 22819930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft.
    Allard E; Jarnet D; Vessières A; Vinchon-Petit S; Jaouen G; Benoit JP; Passirani C
    Pharm Res; 2010 Jan; 27(1):56-64. PubMed ID: 19908129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model.
    Allard E; Huynh NT; Vessières A; Pigeon P; Jaouen G; Benoit JP; Passirani C
    Int J Pharm; 2009 Sep; 379(2):317-23. PubMed ID: 19467309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules.
    Laine AL; Huynh NT; Clavreul A; Balzeau J; Béjaud J; Vessieres A; Benoit JP; Eyer J; Passirani C
    Eur J Pharm Biopharm; 2012 Aug; 81(3):690-3. PubMed ID: 22561953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors.
    Roger M; Clavreul A; Venier-Julienne MC; Passirani C; Sindji L; Schiller P; Montero-Menei C; Menei P
    Biomaterials; 2010 Nov; 31(32):8393-401. PubMed ID: 20688391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
    Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
    Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas.
    Allard E; Passirani C; Garcion E; Pigeon P; Vessières A; Jaouen G; Benoit JP
    J Control Release; 2008 Sep; 130(2):146-53. PubMed ID: 18582507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect.
    Huynh NT; Morille M; Bejaud J; Legras P; Vessieres A; Jaouen G; Benoit JP; Passirani C
    Pharm Res; 2011 Dec; 28(12):3189-98. PubMed ID: 21691892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy.
    Roger M; Clavreul A; Venier-Julienne MC; Passirani C; Montero-Menei C; Menei P
    Biomaterials; 2011 Mar; 32(8):2106-16. PubMed ID: 21183214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient ferrocifen anticancer drug and Bcl-2 gene therapy using lipid nanocapsules on human melanoma xenograft in mouse.
    Resnier P; Galopin N; Sibiril Y; Clavreul A; Cayon J; Briganti A; Legras P; Vessières A; Montier T; Jaouen G; Benoit JP; Passirani C
    Pharmacol Res; 2017 Dec; 126():54-65. PubMed ID: 28159700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model.
    David S; Carmoy N; Resnier P; Denis C; Misery L; Pitard B; Benoit JP; Passirani C; Montier T
    Int J Pharm; 2012 Feb; 423(1):108-15. PubMed ID: 21726617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat multipotent mesenchymal stromal cells lack long-distance tropism to 3 different rat glioma models.
    Bexell D; Gunnarsson S; Svensson A; Tormin A; Henriques-Oliveira C; Siesjö P; Paul G; Salford LG; Scheding S; Bengzon J
    Neurosurgery; 2012 Mar; 70(3):731-9. PubMed ID: 21869725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma.
    Clavreul A; Roger E; Pourbaghi-Masouleh M; Lemaire L; Tétaud C; Menei P
    Drug Deliv; 2018 Nov; 25(1):1756-1765. PubMed ID: 30338715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.